143 related articles for article (PubMed ID: 10971124)
1. Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various nonhematological diseases.
Tanggo Y; Gultom SP; Simanjuntak T; Sibuea WH; Matsuzaki H; Yamaguchi K
Intervirology; 2000; 43(2):77-9. PubMed ID: 10971124
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O
Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria.
Takao S; Ishida T; Bhatia KK; Saha N; Soemantri A; Kayame OW
J Clin Virol; 2000 Apr; 16(2):129-33. PubMed ID: 10720817
[TBL] [Abstract][Full Text] [Related]
7. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
8. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
9. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
12. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
13. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
16. Human T cell lymphotropic virus type 1 in Zimbabwe.
Houston S; Thornton C; Emmanuel J; Latif A
Trans R Soc Trop Med Hyg; 1994; 88(2):170-2. PubMed ID: 8036662
[TBL] [Abstract][Full Text] [Related]
17. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
18. [Antibodies against human T-cell lymphotropic viruses in subjects at high risk for HIV in Monterrey].
Flores-Castañeda MS; Salinas-Carmona MC; Leal-González C; Yáñez-Rodríguez A; Trejo-Avila LM
Rev Invest Clin; 1992; 44(1):37-41. PubMed ID: 1523348
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
[TBL] [Abstract][Full Text] [Related]
20. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
